Hybrid Conferencee

International Conference on Vaccines and Clinical Trials (ICVCT - 26)

17th - 18th October 2026 | Miami, USA

10% DISCOUNT

Maximum discount capped at $30. Activate your Scholarly Discount during the payment phase to lower your final checkout amount.

REVEAL OFFER
EARLY10
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Conference Notifications:

"Be sure to check this section regularly for all Research Plus International Conference updates. We’ll keep you informed about deadlines, event details, and more important notifications."

Call for Papers Extended:
"The deadline for full paper submissions has been extended for the Research Plus International Conference in Miami. Submit your research by today to participate in one of the top conferences."
Certificate of Presentation:
"Present your research and receive a Certificate of Presentation to recognise your valuable contribution to the conference."
Abstract Submissions Open:
"Abstract submissions for the Miami event are now open! Don’t miss the chance to present your research. Submit now."
Networking with Global Experts:
"Engage with researchers and professionals from around the world at the Miami conference. Build collaborations and gain insights from leading experts."
Keynote Speaker Sessions:
"Don’t miss our Keynote Sessions in Miami, featuring global leaders and innovators sharing their knowledge."
Best Paper & Best Paper Presentation Award:
"Submit your paper and stand a chance to win the Best Paper Presentation Award. The winner will be recognized at the conference in Miami."
SDG-Inspired Conference Focus:
"Our conference will highlight research that addresses global sustainability, inclusive education, and solutions for environmental challenges."

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

SDG 3
SDG 3 Good Health and Well-being
SDG 9
SDG 9 Industry, Innovation and Infrastructure
SDG 16
SDG 16 Peace, Justice and Strong Institutions
Track 01

Innovations in Vaccine Trial Design

This track focuses on the latest methodologies and innovative approaches in the design of vaccine clinical trials. Emphasis will be placed on adaptive trial designs and their implications for improving trial efficiency and outcomes.

Track 02

Safety Evaluation in Vaccine Development

This session will explore the critical aspects of safety evaluation in vaccine trials, including methodologies for monitoring adverse events. Participants will discuss best practices for ensuring participant safety and regulatory compliance.

Track 03

Efficacy Assessment of Vaccines

This track will delve into the various strategies for assessing vaccine efficacy during clinical trials. Discussions will include statistical methods, endpoints, and the role of real-world evidence in efficacy evaluation.

Track 04

Regulatory Affairs in Vaccine Trials

This session will address the regulatory landscape governing vaccine clinical trials, including the role of agencies such as the FDA and EMA. Experts will discuss the challenges and opportunities in navigating regulatory requirements.

Track 05

Data Management and Analysis in Vaccine Trials

This track will focus on the importance of data management and statistical analysis in the context of vaccine clinical trials. Topics will include data integrity, analysis techniques, and the use of technology in data collection.

Track 06

Licensing and Market Authorization of Vaccines

This session will cover the processes involved in obtaining licensing and market authorization for vaccines post-trial. Experts will discuss the implications of regulatory pathways and the importance of compliance.

Track 07

Adverse Events Monitoring in Clinical Trials

This track will examine the methodologies for monitoring and reporting adverse events in vaccine clinical trials. The importance of transparency and ethical considerations in adverse event management will be highlighted.

Track 08

Ethical Considerations in Vaccine Trials

This session will explore the ethical implications of conducting vaccine clinical trials, including informed consent and participant rights. Discussions will focus on balancing scientific advancement with ethical responsibilities.

Track 09

Global Perspectives on Vaccine Trials

This track will provide insights into the global landscape of vaccine clinical trials, highlighting differences in regulatory frameworks and trial designs across regions. Participants will share experiences and best practices from diverse settings.

Track 10

Community Engagement in Vaccine Research

This session will discuss the importance of community engagement in the design and implementation of vaccine trials. Strategies for building trust and fostering collaboration with communities will be explored.

Track 11

Future Directions in Vaccine Research

This track will focus on emerging trends and future directions in vaccine research and clinical trials. Topics will include novel vaccine technologies, personalized medicine approaches, and the impact of global health challenges.